Adaptin Bio (APTN) Accounts Payables (2022 - 2026)

Adaptin Bio's Accounts Payables history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 319.29% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 319.29% YoY), while the FY2025 annual figure was $1.5 million, up 11.09% from the prior year.
• Accounts Payables came in at $1.4 million for Q1 2026 at Adaptin Bio, down from $1.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.5 million in Q4 2025 to a low of $58.0 in Q4 2023.
• A 5-year average of $564688.8 and a median of $190091.5 in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 99.54% in 2023 and jumped 2346591.38% in 2024, its largest moves.
• Adaptin Bio's Accounts Payables stood at $12500.0 in 2022, then sank by 99.54% to $58.0 in 2023, then surged by 2346591.38% to $1.4 million in 2024, then advanced by 11.09% to $1.5 million in 2025, then decreased by 9.31% to $1.4 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $1.4 million, $1.5 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison